CD40LG and COVID-19: One of the earliest studies in individuals recovered from COVID-19 found that dengue anti-E IgM kits predominantly showed false-positive results, consistent with IgM being the main cross-reactive antibody class we identified among cross-reactive anti-DENV antibodies (5).